Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 2
2003 6
2004 5
2005 2
2008 1
2009 1
2010 1
2011 1
2012 3
2013 2
2014 3
2015 2
2016 4
2017 3
2018 2
2019 5
2020 8
2021 5
2022 8
2023 14
2024 13
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis.
Fox RJ, Bar-Or A, Traboulsee A, Oreja-Guevara C, Giovannoni G, Vermersch P, Syed S, Li Y, Vargas WS, Turner TJ, Wallstroem E, Reich DS; HERCULES Trial Group. Fox RJ, et al. N Engl J Med. 2025 May 15;392(19):1883-1892. doi: 10.1056/NEJMoa2415988. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202696 Clinical Trial.
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G; Frexalimab Phase 2 Trial Group. Vermersch P, et al. N Engl J Med. 2024 Feb 15;390(7):589-600. doi: 10.1056/NEJMoa2309439. N Engl J Med. 2024. PMID: 38354138 Clinical Trial.
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.
Oh J, Arnold DL, Cree BAC, Ionete C, Kim HJ, Sormani MP, Syed S, Chen Y, Maxwell CR, Benoit P, Turner TJ, Wallstroem E, Wiendl H; Tolebrutinib Phase 3 GEMINI 1 and 2 Trial Group. Oh J, et al. N Engl J Med. 2025 May 15;392(19):1893-1904. doi: 10.1056/NEJMoa2415985. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202623 Clinical Trial.
Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries.
GlobalSurg Collaborative and National Institute for Health Research Global Health Research Unit on Global Surgery. GlobalSurg Collaborative and National Institute for Health Research Global Health Research Unit on Global Surgery. Lancet. 2021 Jan 30;397(10272):387-397. doi: 10.1016/S0140-6736(21)00001-5. Epub 2021 Jan 21. Lancet. 2021. PMID: 33485461 Free PMC article.
Technology Roadmap of Micro/Nanorobots.
Ju X, Chen C, Oral CM, Sevim S, Golestanian R, Sun M, Bouzari N, Lin X, Urso M, Nam JS, Cho Y, Peng X, Landers FC, Yang S, Adibi A, Taz N, Wittkowski R, Ahmed D, Wang W, Magdanz V, Medina-Sánchez M, Guix M, Bari N, Behkam B, Kapral R, Huang Y, Tang J, Wang B, Morozov K, Leshansky A, Abbasi SA, Choi H, Ghosh S, Borges Fernandes B, Battaglia G, Fischer P, Ghosh A, Jurado Sánchez B, Escarpa A, Martinet Q, Palacci J, Lauga E, Moran J, Ramos-Docampo MA, Städler B, Herrera Restrepo RS, Yossifon G, Nicholas JD, Ignés-Mullol J, Puigmartí-Luis J, Liu Y, Zarzar LD, Shields CW 4th, Li L, Li S, Ma X, Gracias DH, Velev O, Sánchez S, Esplandiu MJ, Simmchen J, Lobosco A, Misra S, Wu Z, Li J, Kuhn A, Nourhani A, Maric T, Xiong Z, Aghakhani A, Mei Y, Tu Y, Peng F, Diller E, Sakar MS, Sen A, Law J, Sun Y, Pena-Francesch A, Villa K, Li H, Fan DE, Liang K, Huang TJ, Chen XZ, Tang S, Zhang X, Cui J, Wang H, Gao W, Kumar Bandari V, Schmidt OG, Wu X, Guan J, Sitti M, Nelson BJ, Pané S, Zhang L, Shahsavan H, He Q, Kim ID, Wang J, Pumera M. Ju X, et al. Among authors: sevim s. ACS Nano. 2025 Jul 15;19(27):24174-24334. doi: 10.1021/acsnano.5c03911. Epub 2025 Jun 27. ACS Nano. 2025. PMID: 40577644 Free PMC article. Review.
MOFBOTS: Metal-Organic-Framework-Based Biomedical Microrobots.
Wang X, Chen XZ, Alcântara CCJ, Sevim S, Hoop M, Terzopoulou A, de Marco C, Hu C, de Mello AJ, Falcaro P, Furukawa S, Nelson BJ, Puigmartí-Luis J, Pané S. Wang X, et al. Among authors: sevim s. Adv Mater. 2019 Jul;31(27):e1901592. doi: 10.1002/adma.201901592. Epub 2019 May 6. Adv Mater. 2019. PMID: 31058366
Primary epithelioid angiosarcoma of endometrium.
Sevim S, Gedik E, Ozakinci H, Kaygusuz G, Enneli D. Sevim S, et al. Pol J Pathol. 2023;74(3):219-222. doi: 10.5114/pjp.2023.132302. Pol J Pathol. 2023. PMID: 37955542 Free article.
SERS Barcode Libraries: A Microfluidic Approach.
Sevim S, Franco C, Chen XZ, Sorrenti A, Rodríguez-San-Miguel D, Pané S, deMello AJ, Puigmartí-Luis J. Sevim S, et al. Adv Sci (Weinh). 2020 Apr 22;7(12):1903172. doi: 10.1002/advs.201903172. eCollection 2020 Jun. Adv Sci (Weinh). 2020. PMID: 32596108 Free PMC article.
95 results